Report Detail

Service & Software Global Cell Therapy CDMO Market Growth (Status and Outlook) 2022-2028

  • RnM4490361
  • |
  • 14 September, 2022
  • |
  • Global
  • |
  • 124 Pages
  • |
  • LPI(LP Information)
  • |
  • Service & Software

The global market for Cell Therapy CDMO is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

The APAC Cell Therapy CDMO market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The United States Cell Therapy CDMO market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The Europe Cell Therapy CDMO market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The China Cell Therapy CDMO market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

Global key Cell Therapy CDMO players cover Charles River, The Discovery Labs, BIOCENTRIQ, FUJIFILM Diosynth Biotechnologies and Exothera, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

Report Coverage
This latest report provides a deep insight into the global Cell Therapy CDMO market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.

This report aims to provide a comprehensive picture of the global Cell Therapy CDMO market, with both quantitative and qualitative data, to help readers understand how the Cell Therapy CDMO market scenario changed across the globe during the pandemic and Russia-Ukraine War.

The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.

Market Segmentation:
The study segments the Cell Therapy CDMO market and forecasts the market size by Type (Stem Cell and Non-Stem Cell,), by Application (Commercial, Academic Research and Others,), and region (APAC, Americas, Europe, and Middle East & Africa).

Segmentation by type
Stem Cell
Non-Stem Cell

Segmentation by application
Commercial
Academic Research
Others

Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Major companies covered
Charles River
The Discovery Labs
BIOCENTRIQ
FUJIFILM Diosynth Biotechnologies
Exothera
WuXi AppTec
Pharmaron
OBiO
Cell Therapies
AGC Biologics
Cytiva
Helixmith
ThermoGenesis
Anemocyte
Thermo Fisher Scientific
CBM
Bio Elpida
Genezen
CCRM
RoslinCT
GenScript ProBio

Chapter Introduction
Chapter 1: Scope of Cell Therapy CDMO, Research Methodology, etc.
Chapter 2: Executive Summary, global Cell Therapy CDMO market size and CAGR, Cell Therapy CDMO market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Cell Therapy CDMO revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Cell Therapy CDMO revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Cell Therapy CDMO market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Charles River, The Discovery Labs, BIOCENTRIQ, FUJIFILM Diosynth Biotechnologies, Exothera, WuXi AppTec, Pharmaron, OBiO and Cell Therapies, etc.
Chapter 14: Research Findings and Conclusion


1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Cell Therapy CDMO Market Size 2017-2028
    • 2.1.2 Cell Therapy CDMO Market Size CAGR by Region 2017 VS 2022 VS 2028
  • 2.2 Cell Therapy CDMO Segment by Type
    • 2.2.1 Stem Cell
    • 2.2.2 Non-Stem Cell
  • 2.3 Cell Therapy CDMO Market Size by Type
    • 2.3.1 Cell Therapy CDMO Market Size CAGR by Type (2017 VS 2022 VS 2028)
    • 2.3.2 Global Cell Therapy CDMO Market Size Market Share by Type (2017-2022)
  • 2.4 Cell Therapy CDMO Segment by Application
    • 2.4.1 Commercial
    • 2.4.2 Academic Research
    • 2.4.3 Others
  • 2.5 Cell Therapy CDMO Market Size by Application
    • 2.5.1 Cell Therapy CDMO Market Size CAGR by Application (2017 VS 2022 VS 2028)
    • 2.5.2 Global Cell Therapy CDMO Market Size Market Share by Application (2017-2022)

3 Cell Therapy CDMO Market Size by Player

  • 3.1 Cell Therapy CDMO Market Size Market Share by Players
    • 3.1.1 Global Cell Therapy CDMO Revenue by Players (2020-2022)
    • 3.1.2 Global Cell Therapy CDMO Revenue Market Share by Players (2020-2022)
  • 3.2 Global Cell Therapy CDMO Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
    • 3.3.1 Competition Landscape Analysis
    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion

4 Cell Therapy CDMO by Regions

  • 4.1 Cell Therapy CDMO Market Size by Regions (2017-2022)
  • 4.2 Americas Cell Therapy CDMO Market Size Growth (2017-2022)
  • 4.3 APAC Cell Therapy CDMO Market Size Growth (2017-2022)
  • 4.4 Europe Cell Therapy CDMO Market Size Growth (2017-2022)
  • 4.5 Middle East & Africa Cell Therapy CDMO Market Size Growth (2017-2022)

5 Americas

  • 5.1 Americas Cell Therapy CDMO Market Size by Country (2017-2022)
  • 5.2 Americas Cell Therapy CDMO Market Size by Type (2017-2022)
  • 5.3 Americas Cell Therapy CDMO Market Size by Application (2017-2022)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Cell Therapy CDMO Market Size by Region (2017-2022)
  • 6.2 APAC Cell Therapy CDMO Market Size by Type (2017-2022)
  • 6.3 APAC Cell Therapy CDMO Market Size by Application (2017-2022)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe Cell Therapy CDMO by Country (2017-2022)
  • 7.2 Europe Cell Therapy CDMO Market Size by Type (2017-2022)
  • 7.3 Europe Cell Therapy CDMO Market Size by Application (2017-2022)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Cell Therapy CDMO by Region (2017-2022)
  • 8.2 Middle East & Africa Cell Therapy CDMO Market Size by Type (2017-2022)
  • 8.3 Middle East & Africa Cell Therapy CDMO Market Size by Application (2017-2022)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Global Cell Therapy CDMO Market Forecast

  • 10.1 Global Cell Therapy CDMO Forecast by Regions (2023-2028)
    • 10.1.1 Global Cell Therapy CDMO Forecast by Regions (2023-2028)
    • 10.1.2 Americas Cell Therapy CDMO Forecast
    • 10.1.3 APAC Cell Therapy CDMO Forecast
    • 10.1.4 Europe Cell Therapy CDMO Forecast
    • 10.1.5 Middle East & Africa Cell Therapy CDMO Forecast
  • 10.2 Americas Cell Therapy CDMO Forecast by Country (2023-2028)
    • 10.2.1 United States Cell Therapy CDMO Market Forecast
    • 10.2.2 Canada Cell Therapy CDMO Market Forecast
    • 10.2.3 Mexico Cell Therapy CDMO Market Forecast
    • 10.2.4 Brazil Cell Therapy CDMO Market Forecast
  • 10.3 APAC Cell Therapy CDMO Forecast by Region (2023-2028)
    • 10.3.1 China Cell Therapy CDMO Market Forecast
    • 10.3.2 Japan Cell Therapy CDMO Market Forecast
    • 10.3.3 Korea Cell Therapy CDMO Market Forecast
    • 10.3.4 Southeast Asia Cell Therapy CDMO Market Forecast
    • 10.3.5 India Cell Therapy CDMO Market Forecast
    • 10.3.6 Australia Cell Therapy CDMO Market Forecast
  • 10.4 Europe Cell Therapy CDMO Forecast by Country (2023-2028)
    • 10.4.1 Germany Cell Therapy CDMO Market Forecast
    • 10.4.2 France Cell Therapy CDMO Market Forecast
    • 10.4.3 UK Cell Therapy CDMO Market Forecast
    • 10.4.4 Italy Cell Therapy CDMO Market Forecast
    • 10.4.5 Russia Cell Therapy CDMO Market Forecast
  • 10.5 Middle East & Africa Cell Therapy CDMO Forecast by Region (2023-2028)
    • 10.5.1 Egypt Cell Therapy CDMO Market Forecast
    • 10.5.2 South Africa Cell Therapy CDMO Market Forecast
    • 10.5.3 Israel Cell Therapy CDMO Market Forecast
    • 10.5.4 Turkey Cell Therapy CDMO Market Forecast
    • 10.5.5 GCC Countries Cell Therapy CDMO Market Forecast
  • 10.6 Global Cell Therapy CDMO Forecast by Type (2023-2028)
  • 10.7 Global Cell Therapy CDMO Forecast by Application (2023-2028)

11 Key Players Analysis

  • 11.1 Charles River
    • 11.1.1 Charles River Company Information
    • 11.1.2 Charles River Cell Therapy CDMO Product Offered
    • 11.1.3 Charles River Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2022)
    • 11.1.4 Charles River Main Business Overview
    • 11.1.5 Charles River Latest Developments
  • 11.2 The Discovery Labs
    • 11.2.1 The Discovery Labs Company Information
    • 11.2.2 The Discovery Labs Cell Therapy CDMO Product Offered
    • 11.2.3 The Discovery Labs Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2022)
    • 11.2.4 The Discovery Labs Main Business Overview
    • 11.2.5 The Discovery Labs Latest Developments
  • 11.3 BIOCENTRIQ
    • 11.3.1 BIOCENTRIQ Company Information
    • 11.3.2 BIOCENTRIQ Cell Therapy CDMO Product Offered
    • 11.3.3 BIOCENTRIQ Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2022)
    • 11.3.4 BIOCENTRIQ Main Business Overview
    • 11.3.5 BIOCENTRIQ Latest Developments
  • 11.4 FUJIFILM Diosynth Biotechnologies
    • 11.4.1 FUJIFILM Diosynth Biotechnologies Company Information
    • 11.4.2 FUJIFILM Diosynth Biotechnologies Cell Therapy CDMO Product Offered
    • 11.4.3 FUJIFILM Diosynth Biotechnologies Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2022)
    • 11.4.4 FUJIFILM Diosynth Biotechnologies Main Business Overview
    • 11.4.5 FUJIFILM Diosynth Biotechnologies Latest Developments
  • 11.5 Exothera
    • 11.5.1 Exothera Company Information
    • 11.5.2 Exothera Cell Therapy CDMO Product Offered
    • 11.5.3 Exothera Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2022)
    • 11.5.4 Exothera Main Business Overview
    • 11.5.5 Exothera Latest Developments
  • 11.6 WuXi AppTec
    • 11.6.1 WuXi AppTec Company Information
    • 11.6.2 WuXi AppTec Cell Therapy CDMO Product Offered
    • 11.6.3 WuXi AppTec Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2022)
    • 11.6.4 WuXi AppTec Main Business Overview
    • 11.6.5 WuXi AppTec Latest Developments
  • 11.7 Pharmaron
    • 11.7.1 Pharmaron Company Information
    • 11.7.2 Pharmaron Cell Therapy CDMO Product Offered
    • 11.7.3 Pharmaron Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2022)
    • 11.7.4 Pharmaron Main Business Overview
    • 11.7.5 Pharmaron Latest Developments
  • 11.8 OBiO
    • 11.8.1 OBiO Company Information
    • 11.8.2 OBiO Cell Therapy CDMO Product Offered
    • 11.8.3 OBiO Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2022)
    • 11.8.4 OBiO Main Business Overview
    • 11.8.5 OBiO Latest Developments
  • 11.9 Cell Therapies
    • 11.9.1 Cell Therapies Company Information
    • 11.9.2 Cell Therapies Cell Therapy CDMO Product Offered
    • 11.9.3 Cell Therapies Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2022)
    • 11.9.4 Cell Therapies Main Business Overview
    • 11.9.5 Cell Therapies Latest Developments
  • 11.10 AGC Biologics
    • 11.10.1 AGC Biologics Company Information
    • 11.10.2 AGC Biologics Cell Therapy CDMO Product Offered
    • 11.10.3 AGC Biologics Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2022)
    • 11.10.4 AGC Biologics Main Business Overview
    • 11.10.5 AGC Biologics Latest Developments
  • 11.11 Cytiva
    • 11.11.1 Cytiva Company Information
    • 11.11.2 Cytiva Cell Therapy CDMO Product Offered
    • 11.11.3 Cytiva Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2022)
    • 11.11.4 Cytiva Main Business Overview
    • 11.11.5 Cytiva Latest Developments
  • 11.12 Helixmith
    • 11.12.1 Helixmith Company Information
    • 11.12.2 Helixmith Cell Therapy CDMO Product Offered
    • 11.12.3 Helixmith Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2022)
    • 11.12.4 Helixmith Main Business Overview
    • 11.12.5 Helixmith Latest Developments
  • 11.13 ThermoGenesis
    • 11.13.1 ThermoGenesis Company Information
    • 11.13.2 ThermoGenesis Cell Therapy CDMO Product Offered
    • 11.13.3 ThermoGenesis Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2022)
    • 11.13.4 ThermoGenesis Main Business Overview
    • 11.13.5 ThermoGenesis Latest Developments
  • 11.14 Anemocyte
    • 11.14.1 Anemocyte Company Information
    • 11.14.2 Anemocyte Cell Therapy CDMO Product Offered
    • 11.14.3 Anemocyte Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2022)
    • 11.14.4 Anemocyte Main Business Overview
    • 11.14.5 Anemocyte Latest Developments
  • 11.15 Thermo Fisher Scientific
    • 11.15.1 Thermo Fisher Scientific Company Information
    • 11.15.2 Thermo Fisher Scientific Cell Therapy CDMO Product Offered
    • 11.15.3 Thermo Fisher Scientific Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2022)
    • 11.15.4 Thermo Fisher Scientific Main Business Overview
    • 11.15.5 Thermo Fisher Scientific Latest Developments
  • 11.16 CBM
    • 11.16.1 CBM Company Information
    • 11.16.2 CBM Cell Therapy CDMO Product Offered
    • 11.16.3 CBM Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2022)
    • 11.16.4 CBM Main Business Overview
    • 11.16.5 CBM Latest Developments
  • 11.17 Bio Elpida
    • 11.17.1 Bio Elpida Company Information
    • 11.17.2 Bio Elpida Cell Therapy CDMO Product Offered
    • 11.17.3 Bio Elpida Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2022)
    • 11.17.4 Bio Elpida Main Business Overview
    • 11.17.5 Bio Elpida Latest Developments
  • 11.18 Genezen
    • 11.18.1 Genezen Company Information
    • 11.18.2 Genezen Cell Therapy CDMO Product Offered
    • 11.18.3 Genezen Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2022)
    • 11.18.4 Genezen Main Business Overview
    • 11.18.5 Genezen Latest Developments
  • 11.19 CCRM
    • 11.19.1 CCRM Company Information
    • 11.19.2 CCRM Cell Therapy CDMO Product Offered
    • 11.19.3 CCRM Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2022)
    • 11.19.4 CCRM Main Business Overview
    • 11.19.5 CCRM Latest Developments
  • 11.20 RoslinCT
    • 11.20.1 RoslinCT Company Information
    • 11.20.2 RoslinCT Cell Therapy CDMO Product Offered
    • 11.20.3 RoslinCT Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2022)
    • 11.20.4 RoslinCT Main Business Overview
    • 11.20.5 RoslinCT Latest Developments
  • 11.21 GenScript ProBio
    • 11.21.1 GenScript ProBio Company Information
    • 11.21.2 GenScript ProBio Cell Therapy CDMO Product Offered
    • 11.21.3 GenScript ProBio Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2022)
    • 11.21.4 GenScript ProBio Main Business Overview
    • 11.21.5 GenScript ProBio Latest Developments

12 Research Findings and Conclusion

Summary:
Get latest Market Research Reports on Cell Therapy CDMO. Industry analysis & Market Report on Cell Therapy CDMO is a syndicated market report, published as Global Cell Therapy CDMO Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Cell Therapy CDMO market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,660.00
$7,320.00
3,246.42
6,492.84
3,733.20
7,466.40
529,236.00
1,058,472.00
298,326.60
596,653.20
Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report